nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An immune system fighting against pneumococcus
|
Ruiz-Ruiz, C. |
|
|
25 |
3 |
p. 415-419 |
artikel |
2 |
Anti-SARS-CoV-2 Omicron BA.5 RBD antibody titers generated by the protein subunit vaccine Abdala in breast milk
|
Pérez-Bernal, Maylin |
|
|
25 |
3 |
p. 331-339 |
artikel |
3 |
Controversy on fair and exclusive vaccine decisions for controlling infectious diseases among medical professionals in LMICs. Embracing the Trans-Theoretical Model for Moving Forward
|
Jabeen, Rawshan |
|
|
25 |
3 |
p. 367-373 |
artikel |
4 |
COVID-19 vaccination and concerns regarding the maternal and neonatal safety outcomes
|
Narouiepour, Abdolreza |
|
|
25 |
3 |
p. 428-429 |
artikel |
5 |
COVID-19 vaccine rumour and resistance in Indonesia: Analysing vaccine hesitancy and cultural myths circulated on online platforms
|
Ida, Rachmah |
|
|
25 |
3 |
p. 313-322 |
artikel |
6 |
Decalogue of best practices in vaccine communication between immunocompromised patients and healthcare professionals
|
Fernández-Prada, María |
|
|
25 |
3 |
p. 420-423 |
artikel |
7 |
Immunoinformatics strategy for designing a multi-epitope chimeric vaccine to combat Neisseria gonorrhoeae
|
Priyamvada, P. |
|
|
25 |
3 |
p. 385-402 |
artikel |
8 |
Importance of national regulatory agencies and national control laboratories in the face of the COVID-19 pandemic: Experience of Federal Commission for the Protection against Sanitary Risks (COFEPRIS)
|
Guzmán-Cervantes, Imelda Rocío |
|
|
25 |
3 |
p. 424-427 |
artikel |
9 |
Incidence of neurological complication symptoms post-mRNA vaccination among the urban population of Makkah Province of Kingdom of Saudi Arabia
|
Alsubaie, Abeer Saad |
|
|
25 |
3 |
p. 292-303 |
artikel |
10 |
Influence of new tools to increase the rate of influenza vaccination in patients considered at risk during the campaigns of 2019, 2020 and 2021
|
Santos López, Beatriz |
|
|
25 |
3 |
p. 340-346 |
artikel |
11 |
Musculoskeletal and neuromuscular dysfunction due to covid-19 infection: A review
|
Chauhan, Vivek |
|
|
25 |
3 |
p. 355-366 |
artikel |
12 |
Post COVID-19 era: Re-emergence of known and future (X) viral pathogens
|
Thakur, Pryanka |
|
|
25 |
3 |
p. 403-414 |
artikel |
13 |
Returning to trivalent vaccines against human influenza
|
Reina, Jordi |
|
|
25 |
3 |
p. 289-291 |
artikel |
14 |
SARS-CoV-2 vaccination effect over coagulation in 60s patients treated with acenocumarol
|
Almodóvar-Fernández, Isabel |
|
|
25 |
3 |
p. 323-330 |
artikel |
15 |
Social media as a supporting mechanism during COVID-19 in Indonesia: A quantitative study on isolation among elders
|
Mashud, Mustain |
|
|
25 |
3 |
p. 347-354 |
artikel |
16 |
The emerging applications of niosome as a nanotechnology-based approach in vaccine delivery
|
Talebi, Marjan |
|
|
25 |
3 |
p. 374-384 |
artikel |
17 |
The immunization questionnaire for understanding unwellness (TIQUU): Fun learning about vaccination using an innovative storytelling approach
|
Butt, Waqaas A. |
|
|
25 |
3 |
p. 304-312 |
artikel |